ConductScience.org, home

Paper42902412PubMed

Nanoengineered STING agonists for cancer therapy: toward immunodynamic control.

Liu N and 7 others. J Hematol Oncol, 2026.

Cite this record

ConductScience Library. Nanoengineered STING agonists for cancer therapy: toward immunodynamic control. Papers, record 42902412. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42902412

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nanoengineered STING agonists for cancer therapy: toward immunodynamic control.
Journal
J Hematol Oncol
Year
2026
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
Revised in PubMed
2026-10-31

Source PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu NNaimeng
2Wang XXiangyu
3Zhang WWenxiang
4Kan YYonemori
5Petrovna BMBaranova Madina
6Wang ZZhongzhao
7Kong XXiangyi
8Wang JJing

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Membrane ProteinsMajor topic
Antineoplastic AgentsMajor topic
Humans
STING Protein
Animals
cGAS-STING Signaling Pathway
Immunotherapy
Nanomedicine
Signal Transduction
Nanoparticles

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No. 7252117the Beijing Municipal Natural Science FoundationPubMed
No. 82371842Natural Science Foundation of ChinaPubMed
No. 2024-I2M-ZH-006the CAMS Innovation Fund for Medical Sciences (CIFMS)PubMed

Source PubMed

Download CSV of grants

References212

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129292386The ER membrane adaptor ERAdP senses the bacterial second messenger c-di-AMP and initiates anti-bacterial immunity.Nat Immunol2018https://conductscience.org/library/papers/29292386PubMed
238193384An Immunocompetent Hafnium Oxide-Based STING Nanoagonist for Cancer Radio-immunotherapy.ACS Nano2024https://conductscience.org/library/papers/38193384PubMed
336375786Amplifying STING activation by bioinspired nanomedicine for targeted chemo- and immunotherapy of acute myeloid leukemia.Acta Biomater2023https://conductscience.org/library/papers/36375786PubMed
438531218Feedback activation of CD73-Adenosine axis attenuates the antitumor immunity of STING pathway.Biochem Biophys Res Commun2024https://conductscience.org/library/papers/38531218PubMed
525959818Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.Cell Rep2015https://conductscience.org/library/papers/25959818PubMed
636959214STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma.Nat Commun2023https://conductscience.org/library/papers/36959214PubMed
721709202Randomized phase III placebo-controlled trial of carboplatin and paclitaxel with or without the vascular disrupting agent vadimezan (ASA404) in advanced non-small-cell lung cancer.J Clin Oncol2011https://conductscience.org/library/papers/21709202PubMed
836968140Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction.Cancer Res Commun2023https://conductscience.org/library/papers/36968140PubMed
940068600Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy.Cancer Cell2025https://conductscience.org/library/papers/40068600PubMed
1041573551The cGAS-STING signaling pathway: emerging targets and challenges in breast cancer immunotherapy.Front Immunol2025https://conductscience.org/library/papers/41573551PubMed
1132863398Engineering of Nanoscale Coordination Polymers with Biomolecules for Advanced Applications.Coord Chem Rev2019https://conductscience.org/library/papers/32863398PubMed
1240404668Neoantigen enriched biomimetic nanovaccine for personalized cancer immunotherapy.Nat Commun2025https://conductscience.org/library/papers/40404668PubMed
1340854819Where does ISAC (immune-stimulating antibody conjugates) go from here?J Immunother Cancer2025https://conductscience.org/library/papers/40854819PubMed
1436280710Intercellular transfer of activated STING triggered by RAB22A-mediated non-canonical autophagy promotes antitumor immunity.Cell Res2022https://conductscience.org/library/papers/36280710PubMed
1534716197Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas.Clin Cancer Res2022https://conductscience.org/library/papers/34716197PubMed
1634443638Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis.Molecules2021https://conductscience.org/library/papers/34443638PubMed
1736018392DNA damage induces STING mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients.Apoptosis2022https://conductscience.org/library/papers/36018392PubMed
1833372007Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis.Cancer Discov2021https://conductscience.org/library/papers/33372007PubMed
1940213662Photoactivatable immunomodulator polyprodrugs for boosting synergistic antitumor immunity of STING agonists and IDO inhibitors.Theranostics2025https://conductscience.org/library/papers/40213662PubMed
2025642965Mitochondrial DNA stress primes the antiviral innate immune response.Nature2015https://conductscience.org/library/papers/25642965PubMed

See all 212 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42902412

GET https://conductscience.org/api/papers/v1/42902412/references?page=2